TAUSSIG reports 5-year data with evolocumab in severe and homozygous familial hypercholesterolaemia. Professor Eric Bruckert (Pitié-Salpêtrière Hospital, Paris, France) gives his perspective

Read the report »

• EAS Consensus Panel Statement on LDL-driven mechanisms in atherosclerosis: state-of-the-art review
  Read the report »

• DE LAVAL: Evolocumab reduces need for lipoprotein apheresis
  Read the report »

• BEIJERINCK: Unmet needs in dyslipidaema management among people living with HIV
  Read the report »

• Inclisiran: No dose adjustment in patients with renal impairment
  Read the report »

Education: the primary mission of PCSK9 Forum.

Don’t forget to check back for the latest updates to the PCSK9 Forum educational slide resource programme